DataMeds AI settles shareholder litigation, pays $450,000 to repurchase 364,099 shares

• DataMeds AI entered a Sept. 11, 2026 settlement to end Florida state court litigation tied to a May 11, 2023 purchase agreement.
• The deal also resolves a Delaware Chancery action filed by Brian Norton and other selling holders over consideration, obligations, common stock.
• Paid $450,000 total; $350,000 for repurchase and extinguishment of 364,099 common shares; $100,000 to settle released claims.
• Settlement expected to extinguish about $19 million of balance-sheet liability.
• Cases to be dismissed with prejudice; parties agreed to mutual releases.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DataMeds AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-043169), on September 17, 2026, and is solely responsible for the information contained therein.